Trial
NCT00268450
Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Medical University of South Carolina
Collaborators
—
Condition
Bladder Cancer
Intervention
bevacizumab
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-12